CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,841,175 | +47.3% | 157,500 | +69.4% | 0.35% | +52.6% |
| Q2 2023 | $1,249,920 | -18.9% | 93,000 | 0.0% | 0.23% | -5.0% |
| Q1 2023 | $1,541,940 | +33.7% | 93,000 | +50.0% | 0.24% | +28.7% |
| Q4 2022 | $1,153,200 | +45.1% | 62,000 | 0.0% | 0.19% | +37.2% |
| Q3 2022 | $795,000 | -12.7% | 62,000 | -52.3% | 0.14% | -12.7% |
| Q2 2022 | $911,000 | +61.5% | 130,000 | +91.2% | 0.16% | +42.7% |
| Q1 2022 | $564,000 | +22.6% | 68,000 | 0.0% | 0.11% | +8.9% |
| Q4 2021 | $460,000 | -30.0% | 68,000 | -45.2% | 0.10% | -30.3% |
| Q3 2021 | $657,000 | -7.9% | 124,000 | 0.0% | 0.14% | -2.0% |
| Q2 2021 | $713,000 | – | 124,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |